<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000269425"><TermName>PKC412</TermName><TermDefinition><DefinitionText>A substance that is being studied in the treatment of leukemia. It belongs to the family of drugs called protein kinase inhibitors. Also called midostaurin and N-benzoyl-staurosporine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>PKC412</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de la leucemia. Es un tipo de inhibidor de la proteína cinasa. También se llama midostaurin y N-benzoilo-estaurosporina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2002-12-21</DateFirstPublished><DateLastModified>2007-03-15</DateLastModified></GlossaryTerm>
